 |
 |
 |
 |
Return-Path: <owner-cyto-sendout@flowcyt.cyto.purdue.edu>
Received: from msmail by SmtpIn.em.cdc.gov id <314E7F8A@SmtpIn.em.cdc.gov>;
Tue, 19 Mar 96 13:34:02 EST
Received: from flowcyt.cyto.purdue.edu by msmail (5.0/SMI-SVR4) id AA26309;
Tue, 19 Mar 1996 13:35:10 -0500
Received: by flowcyt.cyto.purdue.edu (950215.SGI.8.6.10/930416.SGI.AUTO) for
cyto-sendout id MAA18470; Tue, 19 Mar 1996 12:01:41 -0500
Received: from upsmot01.msn.com by flowcyt.cyto.purdue.edu via ESMTP
(950215.SGI.8.6.10/930416.SGI.AUTO) for
<cytometry@flowcyt.cyto.purdue.edu> id WAA16596; Mon, 18 Mar 1996
22:50:54
-0500
Received: from upmajb04.msn.com ([204.95.110.81]) by upsmot01.msn.com
(8.6.8.1/Configuration 4) with SMTP id TAA14808 for
<cytometry@flowcyt.cyto.purdue.edu>; Mon, 18 Mar 1996 19:40:45 -0800
Date: Tue, 19 Mar 96 03:25:24 UT
From: "Keith Bahjat" <KBahjat@msn.com>
Message-Id: <UPMAIL05.199603190327330458@msn.com>
To: Cytometry Mailing List <cytometry@flowcyt.cyto.purdue.edu>
Subject: Lymph Node Prep
content-length: 526
----------------------------------------------------------------------------
--
Can someone please tell me if there is any benefit to using density gradient
separation on cells from a lymph node (be it a biopsy or FNA) if you are
already using viability gating?
What I saw with viability gating looked pretty straight forward, and I
couldn't see why any separation media would be needed.
I would be interested in any and all experience people have had with the two
techniques.
Thanks in advance.
Keith Bahjat
South Bend Medical Foundation
South Bend, Indiana
219-234-4176 x282
E-mail: Kbahjat@MSN.com
|
|
|
|